Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO14102 | Kadsura interior | Species | Schisandraceae | Eukaryota |
PMID[12350139] |
|||
NPO33401 | schisandra sphenathera | Species | Schisandraceae | Eukaryota | Stems |
PMID[23237974] |
||
NPO25917 | Sorghum sativum | Species | Poaceae | Eukaryota | UNPD* | |||
NPO16407 | Tinospora tuberculata | Species | Menispermaceae | Eukaryota | UNPD* | |||
NPO225 | Eupatorium angustifolium | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO26046 | Pseudogynoxys engleri | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO25679 | Aloe rubroviolacea | Species | Asphodelaceae | Eukaryota | UNPD* | |||
NPO14102 | Kadsura interior | Species | Schisandraceae | Eukaryota | HerDing* | |||
NPO24804 | Schisandra rubriflora | Species | Schisandraceae | Eukaryota | HerDing* | |||
NPO25239 | Kadsura peltigera | Species | Schisandraceae | Eukaryota | HerDing* | |||
NPO7385 | Schisandra sphenanthera | Species | Schisandraceae | Eukaryota | HerDing* | |||
NPO8187 | Schisandra chinensis | Species | Schisandraceae | Eukaryota | TCM_Taiwan* | |||
NPO8187 | Schisandra chinensis | Species | Schisandraceae | Eukaryota | HerDing* | |||
NPO25539 | Alternaria mali | Species | Pleosporaceae | Eukaryota | UNPD* | |||
NPO25648 | Gnaphalium liebmannii | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO26233 | Helenium autumnale | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO25811 | Euphorbia erythraea | Species | Euphorbiaceae | Eukaryota | UNPD* | |||
NPO23979 | Synadenium compactum | NA | NA | NA | UNPD* | |||
NPO1753 | Schisandrae chinensis fructus | NA | NA | NA | TCMSP* | |||
NPO8187 | Schisandra chinensis | Species | Schisandraceae | Eukaryota | TM-MC* | |||
NPO7385 | Schisandra sphenanthera | Species | Schisandraceae | Eukaryota | TM-MC* | |||
NPO25239 | Kadsura peltigera | Species | Schisandraceae | Eukaryota | TCMID* | |||
NPO14102 | Kadsura interior | Species | Schisandraceae | Eukaryota | TCMID* | |||
NPO24804 | Schisandra rubriflora | Species | Schisandraceae | Eukaryota | TCMID* | |||
NPO7385 | Schisandra sphenanthera | Species | Schisandraceae | Eukaryota | TCMID* | |||
NPO8187 | Schisandra chinensis | Species | Schisandraceae | Eukaryota | TCMID* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | > | 100000 | nM | 18063366 |
NPT1086 | Cell Line | SK-HEP1 | Homo sapiens | IC50 | > | 100000 | nM | 18063366 |
NPT2548 | Cell Line | SNU-638 | Homo sapiens | IC50 | > | 100000 | nM | 18063366 |
NPT396 | Cell Line | T47D | Homo sapiens | IC50 | > | 100000 | nM | 18063366 |
NPT148 | Cell Line | HCT-15 | Homo sapiens | IC50 | > | 100000 | nM | 18063366 |
NPT111 | Cell Line | K562 | Homo sapiens | IC50 | > | 100000 | nM | 18063366 |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | > | 100000 | nM | 18063366 |
NPT1114 | Organism | Human immunodeficiency virus | Human immunodeficiency virus | EC50 | = | 1.2 | ug/ml | 14987069 |
NPT1114 | Organism | Human immunodeficiency virus | Human immunodeficiency virus | IC50 | = | 3100 | nM | 9834179 |
NPT2 | Others | Unspecified | Activity | = | 2.6 | % | 12350139 | |
NPT2 | Others | Unspecified | Activity | = | 50.7 | % | 12350139 | |
NPT2 | Others | Unspecified | Activity | = | 73.6 | % | 12350139 | |
NPT2 | Others | Unspecified | Activity | = | 92.1 | % | 12350139 | |
NPT80 | Cell Line | Raji | Homo sapiens | Activity | = | 70 | % | 12350139 |
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 41200 | nM | 16562834 |
NPT2 | Others | Unspecified | IC50 | > | 100000 | nM | 23237974 | |
NPT165 | Cell Line | HeLa | Homo sapiens | IC50 | > | 100000 | nM | 23237974 |
NPT659 | Cell Line | SMMC-7721 | Homo sapiens | IC50 | > | 100000 | nM | 23237974 |
NPT2 | Others | Unspecified | Activity | = | 187 | % | 25302569 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC32189 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9845 | High Similarity | NPC256776 |
0.9845 | High Similarity | NPC145722 |
0.9845 | High Similarity | NPC185680 |
0.9549 | High Similarity | NPC53722 |
0.9549 | High Similarity | NPC290714 |
0.9549 | High Similarity | NPC201404 |
0.9485 | High Similarity | NPC172171 |
0.9485 | High Similarity | NPC239254 |
0.9478 | High Similarity | NPC103448 |
0.9478 | High Similarity | NPC216434 |
0.9416 | High Similarity | NPC475868 |
0.9348 | High Similarity | NPC252286 |
0.9348 | High Similarity | NPC154971 |
0.9338 | High Similarity | NPC133934 |
0.9338 | High Similarity | NPC103637 |
0.9338 | High Similarity | NPC230538 |
0.9338 | High Similarity | NPC229172 |
0.9338 | High Similarity | NPC184684 |
0.9338 | High Similarity | NPC474295 |
0.9338 | High Similarity | NPC36531 |
0.9338 | High Similarity | NPC184641 |
0.927 | High Similarity | NPC324962 |
0.927 | High Similarity | NPC76415 |
0.927 | High Similarity | NPC218510 |
0.9242 | High Similarity | NPC72046 |
0.9242 | High Similarity | NPC261812 |
0.9242 | High Similarity | NPC65183 |
0.9231 | High Similarity | NPC149008 |
0.9231 | High Similarity | NPC207702 |
0.9231 | High Similarity | NPC283114 |
0.9203 | High Similarity | NPC73467 |
0.9203 | High Similarity | NPC121661 |
0.9203 | High Similarity | NPC326144 |
0.9185 | High Similarity | NPC196420 |
0.9173 | High Similarity | NPC266848 |
0.9173 | High Similarity | NPC136750 |
0.9167 | High Similarity | NPC192255 |
0.9149 | High Similarity | NPC85141 |
0.9137 | High Similarity | NPC189239 |
0.9137 | High Similarity | NPC166506 |
0.9137 | High Similarity | NPC197352 |
0.9137 | High Similarity | NPC110763 |
0.9137 | High Similarity | NPC318286 |
0.9137 | High Similarity | NPC327651 |
0.9118 | High Similarity | NPC9068 |
0.9104 | High Similarity | NPC31530 |
0.9098 | High Similarity | NPC7744 |
0.9091 | High Similarity | NPC258483 |
0.9085 | High Similarity | NPC473989 |
0.9071 | High Similarity | NPC321958 |
0.9071 | High Similarity | NPC321696 |
0.9037 | High Similarity | NPC49235 |
0.9037 | High Similarity | NPC25333 |
0.9037 | High Similarity | NPC148893 |
0.9037 | High Similarity | NPC189474 |
0.9037 | High Similarity | NPC150534 |
0.9037 | High Similarity | NPC474139 |
0.9023 | High Similarity | NPC141493 |
0.9023 | High Similarity | NPC184928 |
0.9021 | High Similarity | NPC303519 |
0.8986 | High Similarity | NPC312199 |
0.8971 | High Similarity | NPC197166 |
0.8971 | High Similarity | NPC121651 |
0.8971 | High Similarity | NPC11453 |
0.8955 | High Similarity | NPC102256 |
0.8955 | High Similarity | NPC475856 |
0.8944 | High Similarity | NPC316676 |
0.8944 | High Similarity | NPC198129 |
0.8944 | High Similarity | NPC252281 |
0.8944 | High Similarity | NPC477375 |
0.8944 | High Similarity | NPC325720 |
0.8944 | High Similarity | NPC327352 |
0.8936 | High Similarity | NPC33832 |
0.8936 | High Similarity | NPC87295 |
0.8921 | High Similarity | NPC472562 |
0.8921 | High Similarity | NPC80326 |
0.8905 | High Similarity | NPC283949 |
0.8905 | High Similarity | NPC185908 |
0.8889 | High Similarity | NPC196937 |
0.8881 | High Similarity | NPC322426 |
0.8881 | High Similarity | NPC477374 |
0.8881 | High Similarity | NPC477376 |
0.8873 | High Similarity | NPC116019 |
0.8864 | High Similarity | NPC8050 |
0.8864 | High Similarity | NPC473093 |
0.8864 | High Similarity | NPC473092 |
0.8857 | High Similarity | NPC474808 |
0.8849 | High Similarity | NPC58137 |
0.8849 | High Similarity | NPC300798 |
0.8841 | High Similarity | NPC113550 |
0.8841 | High Similarity | NPC30951 |
0.8841 | High Similarity | NPC6369 |
0.8836 | High Similarity | NPC348849 |
0.8836 | High Similarity | NPC198461 |
0.8836 | High Similarity | NPC312763 |
0.8836 | High Similarity | NPC178195 |
0.8824 | High Similarity | NPC289258 |
0.8824 | High Similarity | NPC7515 |
0.8824 | High Similarity | NPC56764 |
0.8824 | High Similarity | NPC276026 |
0.8824 | High Similarity | NPC188378 |
0.8824 | High Similarity | NPC555 |
0.8824 | High Similarity | NPC206737 |
0.8824 | High Similarity | NPC469659 |
0.8819 | High Similarity | NPC316989 |
0.8797 | High Similarity | NPC328682 |
0.8797 | High Similarity | NPC57119 |
0.8797 | High Similarity | NPC82862 |
0.8797 | High Similarity | NPC54321 |
0.8797 | High Similarity | NPC281864 |
0.8797 | High Similarity | NPC222127 |
0.8797 | High Similarity | NPC158471 |
0.8797 | High Similarity | NPC165128 |
0.8797 | High Similarity | NPC226862 |
0.8786 | High Similarity | NPC174522 |
0.8786 | High Similarity | NPC191231 |
0.8777 | High Similarity | NPC284464 |
0.8777 | High Similarity | NPC46591 |
0.8777 | High Similarity | NPC226547 |
0.8777 | High Similarity | NPC56091 |
0.8777 | High Similarity | NPC177868 |
0.8768 | High Similarity | NPC865 |
0.8759 | High Similarity | NPC240279 |
0.8759 | High Similarity | NPC214853 |
0.8759 | High Similarity | NPC180602 |
0.8759 | High Similarity | NPC55239 |
0.8759 | High Similarity | NPC475756 |
0.8759 | High Similarity | NPC224472 |
0.875 | High Similarity | NPC1474 |
0.8741 | High Similarity | NPC82111 |
0.8741 | High Similarity | NPC227160 |
0.8732 | High Similarity | NPC205316 |
0.8732 | High Similarity | NPC180953 |
0.8722 | High Similarity | NPC471986 |
0.8699 | High Similarity | NPC471154 |
0.8699 | High Similarity | NPC477378 |
0.8699 | High Similarity | NPC220577 |
0.8699 | High Similarity | NPC475229 |
0.8696 | High Similarity | NPC143895 |
0.8696 | High Similarity | NPC133025 |
0.8692 | High Similarity | NPC301641 |
0.8692 | High Similarity | NPC80241 |
0.8686 | High Similarity | NPC90083 |
0.8686 | High Similarity | NPC170779 |
0.8681 | High Similarity | NPC304821 |
0.8667 | High Similarity | NPC184814 |
0.8667 | High Similarity | NPC470624 |
0.8667 | High Similarity | NPC237169 |
0.8667 | High Similarity | NPC271208 |
0.8667 | High Similarity | NPC233224 |
0.8667 | High Similarity | NPC63574 |
0.8652 | High Similarity | NPC287124 |
0.8647 | High Similarity | NPC186845 |
0.8647 | High Similarity | NPC285725 |
0.8647 | High Similarity | NPC9891 |
0.8647 | High Similarity | NPC50683 |
0.8647 | High Similarity | NPC88297 |
0.8647 | High Similarity | NPC112571 |
0.8639 | High Similarity | NPC217708 |
0.8639 | High Similarity | NPC477377 |
0.8639 | High Similarity | NPC77237 |
0.8639 | High Similarity | NPC474514 |
0.8639 | High Similarity | NPC16791 |
0.8639 | High Similarity | NPC297271 |
0.8639 | High Similarity | NPC24562 |
0.8639 | High Similarity | NPC308739 |
0.8639 | High Similarity | NPC474606 |
0.8639 | High Similarity | NPC126405 |
0.8639 | High Similarity | NPC53669 |
0.8636 | High Similarity | NPC283170 |
0.8636 | High Similarity | NPC92869 |
0.8636 | High Similarity | NPC191768 |
0.8633 | High Similarity | NPC86605 |
0.8633 | High Similarity | NPC474039 |
0.8633 | High Similarity | NPC156948 |
0.8633 | High Similarity | NPC3072 |
0.8633 | High Similarity | NPC46277 |
0.8633 | High Similarity | NPC261714 |
0.8633 | High Similarity | NPC301765 |
0.8626 | High Similarity | NPC211231 |
0.8623 | High Similarity | NPC236522 |
0.8613 | High Similarity | NPC471390 |
0.8613 | High Similarity | NPC471391 |
0.8613 | High Similarity | NPC58585 |
0.8592 | High Similarity | NPC474288 |
0.8592 | High Similarity | NPC12728 |
0.8592 | High Similarity | NPC255566 |
0.8592 | High Similarity | NPC298317 |
0.8592 | High Similarity | NPC185071 |
0.8592 | High Similarity | NPC265154 |
0.8582 | High Similarity | NPC189248 |
0.8582 | High Similarity | NPC177167 |
0.8582 | High Similarity | NPC202904 |
0.8581 | High Similarity | NPC473425 |
0.8571 | High Similarity | NPC471183 |
0.8562 | High Similarity | NPC149505 |
0.8561 | High Similarity | NPC78047 |
0.8552 | High Similarity | NPC71726 |
0.855 | High Similarity | NPC477886 |
0.854 | High Similarity | NPC171928 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC32189 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.855 | High Similarity | NPD3705 | Approved |
0.8224 | Intermediate Similarity | NPD4965 | Approved |
0.8224 | Intermediate Similarity | NPD4966 | Approved |
0.8224 | Intermediate Similarity | NPD4967 | Phase 2 |
0.8146 | Intermediate Similarity | NPD37 | Approved |
0.8117 | Intermediate Similarity | NPD6234 | Discontinued |
0.8 | Intermediate Similarity | NPD5283 | Phase 1 |
0.7929 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7914 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7898 | Intermediate Similarity | NPD7199 | Phase 2 |
0.781 | Intermediate Similarity | NPD2981 | Phase 2 |
0.7799 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7764 | Intermediate Similarity | NPD7228 | Approved |
0.7754 | Intermediate Similarity | NPD2982 | Phase 2 |
0.7754 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7718 | Intermediate Similarity | NPD5084 | Clinical (unspecified phase) |
0.7697 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.766 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7606 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7584 | Intermediate Similarity | NPD6674 | Discontinued |
0.7576 | Intermediate Similarity | NPD7240 | Approved |
0.7517 | Intermediate Similarity | NPD1613 | Approved |
0.7517 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7516 | Intermediate Similarity | NPD1940 | Clinical (unspecified phase) |
0.7386 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7383 | Intermediate Similarity | NPD3539 | Phase 1 |
0.7368 | Intermediate Similarity | NPD5307 | Clinical (unspecified phase) |
0.7361 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7333 | Intermediate Similarity | NPD3540 | Phase 1 |
0.732 | Intermediate Similarity | NPD7124 | Phase 2 |
0.731 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7267 | Intermediate Similarity | NPD7975 | Clinical (unspecified phase) |
0.7266 | Intermediate Similarity | NPD1357 | Approved |
0.726 | Intermediate Similarity | NPD5111 | Phase 2 |
0.726 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.726 | Intermediate Similarity | NPD5109 | Approved |
0.726 | Intermediate Similarity | NPD5110 | Phase 2 |
0.7248 | Intermediate Similarity | NPD6111 | Discontinued |
0.7235 | Intermediate Similarity | NPD7090 | Clinical (unspecified phase) |
0.7234 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7222 | Intermediate Similarity | NPD6917 | Clinical (unspecified phase) |
0.7195 | Intermediate Similarity | NPD6232 | Discontinued |
0.7178 | Intermediate Similarity | NPD5494 | Approved |
0.7169 | Intermediate Similarity | NPD7473 | Discontinued |
0.716 | Intermediate Similarity | NPD4055 | Discovery |
0.7152 | Intermediate Similarity | NPD6055 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD4005 | Discontinued |
0.7133 | Intermediate Similarity | NPD4749 | Approved |
0.7133 | Intermediate Similarity | NPD3600 | Clinical (unspecified phase) |
0.7126 | Intermediate Similarity | NPD3818 | Discontinued |
0.7122 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7114 | Intermediate Similarity | NPD3657 | Discovery |
0.7101 | Intermediate Similarity | NPD709 | Approved |
0.7089 | Intermediate Similarity | NPD1653 | Approved |
0.7086 | Intermediate Similarity | NPD4108 | Discontinued |
0.7055 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7047 | Intermediate Similarity | NPD3620 | Phase 2 |
0.7047 | Intermediate Similarity | NPD3619 | Clinical (unspecified phase) |
0.7047 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7019 | Intermediate Similarity | NPD3384 | Approved |
0.7019 | Intermediate Similarity | NPD3383 | Approved |
0.7019 | Intermediate Similarity | NPD3382 | Approved |
0.7 | Intermediate Similarity | NPD7028 | Phase 2 |
0.6993 | Remote Similarity | NPD1375 | Discontinued |
0.6993 | Remote Similarity | NPD1091 | Approved |
0.6982 | Remote Similarity | NPD5844 | Phase 1 |
0.6968 | Remote Similarity | NPD3892 | Phase 2 |
0.6957 | Remote Similarity | NPD5090 | Approved |
0.6957 | Remote Similarity | NPD5089 | Approved |
0.695 | Remote Similarity | NPD1548 | Phase 1 |
0.6946 | Remote Similarity | NPD3926 | Phase 2 |
0.6944 | Remote Similarity | NPD7237 | Clinical (unspecified phase) |
0.6941 | Remote Similarity | NPD7074 | Phase 3 |
0.6934 | Remote Similarity | NPD228 | Approved |
0.6933 | Remote Similarity | NPD3817 | Phase 2 |
0.6933 | Remote Similarity | NPD6374 | Clinical (unspecified phase) |
0.6914 | Remote Similarity | NPD1934 | Approved |
0.6913 | Remote Similarity | NPD6410 | Clinical (unspecified phase) |
0.6913 | Remote Similarity | NPD6859 | Clinical (unspecified phase) |
0.6903 | Remote Similarity | NPD5698 | Clinical (unspecified phase) |
0.6901 | Remote Similarity | NPD1651 | Approved |
0.6901 | Remote Similarity | NPD5691 | Approved |
0.689 | Remote Similarity | NPD3882 | Suspended |
0.6886 | Remote Similarity | NPD7229 | Phase 3 |
0.6882 | Remote Similarity | NPD7054 | Approved |
0.6875 | Remote Similarity | NPD1281 | Approved |
0.6875 | Remote Similarity | NPD1611 | Approved |
0.6871 | Remote Similarity | NPD2801 | Approved |
0.6871 | Remote Similarity | NPD1465 | Phase 2 |
0.6871 | Remote Similarity | NPD4585 | Approved |
0.6863 | Remote Similarity | NPD6029 | Clinical (unspecified phase) |
0.6863 | Remote Similarity | NPD3748 | Approved |
0.6863 | Remote Similarity | NPD6028 | Clinical (unspecified phase) |
0.6859 | Remote Similarity | NPD7466 | Approved |
0.6857 | Remote Similarity | NPD6387 | Discontinued |
0.6853 | Remote Similarity | NPD4626 | Approved |
0.6849 | Remote Similarity | NPD2922 | Phase 1 |
0.6842 | Remote Similarity | NPD7472 | Approved |
0.6839 | Remote Similarity | NPD970 | Clinical (unspecified phase) |
0.6835 | Remote Similarity | NPD4357 | Discontinued |
0.6832 | Remote Similarity | NPD7261 | Clinical (unspecified phase) |
0.6831 | Remote Similarity | NPD5005 | Approved |
0.6831 | Remote Similarity | NPD5006 | Approved |
0.6821 | Remote Similarity | NPD2979 | Phase 3 |
0.6818 | Remote Similarity | NPD2438 | Suspended |
0.6812 | Remote Similarity | NPD1137 | Approved |
0.6812 | Remote Similarity | NPD1139 | Approved |
0.6807 | Remote Similarity | NPD919 | Approved |
0.68 | Remote Similarity | NPD8055 | Clinical (unspecified phase) |
0.6797 | Remote Similarity | NPD6895 | Approved |
0.6797 | Remote Similarity | NPD6896 | Approved |
0.6793 | Remote Similarity | NPD7680 | Approved |
0.6788 | Remote Similarity | NPD3021 | Approved |
0.6788 | Remote Similarity | NPD4868 | Clinical (unspecified phase) |
0.6788 | Remote Similarity | NPD4750 | Phase 3 |
0.6788 | Remote Similarity | NPD3022 | Approved |
0.6786 | Remote Similarity | NPD3787 | Discontinued |
0.6781 | Remote Similarity | NPD5327 | Phase 3 |
0.6781 | Remote Similarity | NPD4379 | Clinical (unspecified phase) |
0.6774 | Remote Similarity | NPD5763 | Approved |
0.6774 | Remote Similarity | NPD5762 | Approved |
0.6774 | Remote Similarity | NPD7266 | Discontinued |
0.6772 | Remote Similarity | NPD6783 | Clinical (unspecified phase) |
0.6772 | Remote Similarity | NPD5058 | Phase 3 |
0.6768 | Remote Similarity | NPD2978 | Approved |
0.6768 | Remote Similarity | NPD2393 | Clinical (unspecified phase) |
0.6768 | Remote Similarity | NPD2977 | Approved |
0.6763 | Remote Similarity | NPD1138 | Approved |
0.6763 | Remote Similarity | NPD6559 | Discontinued |
0.6755 | Remote Similarity | NPD554 | Clinical (unspecified phase) |
0.675 | Remote Similarity | NPD7314 | Clinical (unspecified phase) |
0.6736 | Remote Similarity | NPD5126 | Approved |
0.6736 | Remote Similarity | NPD5125 | Phase 3 |
0.6735 | Remote Similarity | NPD1283 | Approved |
0.6735 | Remote Similarity | NPD6696 | Suspended |
0.6733 | Remote Similarity | NPD2669 | Clinical (unspecified phase) |
0.6732 | Remote Similarity | NPD4097 | Suspended |
0.6731 | Remote Similarity | NPD4664 | Clinical (unspecified phase) |
0.673 | Remote Similarity | NPD5297 | Approved |
0.6726 | Remote Similarity | NPD1247 | Approved |
0.6725 | Remote Similarity | NPD8099 | Discontinued |
0.6725 | Remote Similarity | NPD8252 | Approved |
0.6725 | Remote Similarity | NPD8251 | Approved |
0.6724 | Remote Similarity | NPD7808 | Phase 3 |
0.6723 | Remote Similarity | NPD6842 | Approved |
0.6723 | Remote Similarity | NPD6841 | Approved |
0.6723 | Remote Similarity | NPD6843 | Phase 3 |
0.6711 | Remote Similarity | NPD2238 | Phase 2 |
0.671 | Remote Similarity | NPD6099 | Approved |
0.671 | Remote Similarity | NPD6100 | Approved |
0.6709 | Remote Similarity | NPD2219 | Phase 1 |
0.6705 | Remote Similarity | NPD6797 | Phase 2 |
0.6703 | Remote Similarity | NPD4420 | Approved |
0.6688 | Remote Similarity | NPD4236 | Phase 3 |
0.6688 | Remote Similarity | NPD4237 | Approved |
0.6688 | Remote Similarity | NPD5177 | Phase 3 |
0.6687 | Remote Similarity | NPD4584 | Approved |
0.6687 | Remote Similarity | NPD4675 | Approved |
0.6687 | Remote Similarity | NPD6788 | Approved |
0.6687 | Remote Similarity | NPD4678 | Approved |
0.6687 | Remote Similarity | NPD2534 | Approved |
0.6687 | Remote Similarity | NPD2532 | Approved |
0.6687 | Remote Similarity | NPD2533 | Approved |
0.6686 | Remote Similarity | NPD8156 | Discontinued |
0.6667 | Remote Similarity | NPD6355 | Discontinued |
0.6667 | Remote Similarity | NPD1933 | Approved |
0.6667 | Remote Similarity | NPD4210 | Discontinued |
0.6667 | Remote Similarity | NPD5752 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD5735 | Approved |
0.6667 | Remote Similarity | NPD5451 | Approved |
0.6667 | Remote Similarity | NPD1669 | Approved |
0.6667 | Remote Similarity | NPD7819 | Suspended |
0.6667 | Remote Similarity | NPD7251 | Discontinued |
0.6667 | Remote Similarity | NPD5563 | Clinical (unspecified phase) |
0.6647 | Remote Similarity | NPD4381 | Clinical (unspecified phase) |
0.6647 | Remote Similarity | NPD5242 | Approved |
0.6646 | Remote Similarity | NPD4109 | Clinical (unspecified phase) |
0.6646 | Remote Similarity | NPD5261 | Clinical (unspecified phase) |
0.6646 | Remote Similarity | NPD4110 | Phase 3 |
0.6646 | Remote Similarity | NPD3750 | Approved |
0.6646 | Remote Similarity | NPD6658 | Clinical (unspecified phase) |
0.6644 | Remote Similarity | NPD422 | Phase 1 |
0.6644 | Remote Similarity | NPD4624 | Approved |
0.6643 | Remote Similarity | NPD5535 | Approved |
0.6629 | Remote Similarity | NPD7549 | Discontinued |
0.6629 | Remote Similarity | NPD4338 | Clinical (unspecified phase) |
0.6627 | Remote Similarity | NPD2563 | Approved |
0.6627 | Remote Similarity | NPD2560 | Approved |
0.6627 | Remote Similarity | NPD2358 | Clinical (unspecified phase) |
0.6625 | Remote Similarity | NPD1511 | Approved |
0.6624 | Remote Similarity | NPD1372 | Clinical (unspecified phase) |
0.6624 | Remote Similarity | NPD2808 | Discontinued |
0.6623 | Remote Similarity | NPD2492 | Phase 1 |
0.6622 | Remote Similarity | NPD8651 | Approved |
0.6621 | Remote Similarity | NPD17 | Approved |
0.662 | Remote Similarity | NPD7157 | Approved |
0.6608 | Remote Similarity | NPD6166 | Phase 2 |
0.6608 | Remote Similarity | NPD6167 | Clinical (unspecified phase) |
0.6608 | Remote Similarity | NPD6168 | Clinical (unspecified phase) |
0.6608 | Remote Similarity | NPD4481 | Phase 3 |
PubChem CID   | 443027 |
ChEMBL   | CHEMBL437412 |
ZINC   |
Molecular Weight:   | 384.16 |
ALogP:   | 0.2002 |
MLogP:   | 3.22 |
XLogP:   | 4.41 |
# Rotatable Bonds:   | 6 |
Polar Surface Area:   | 55.38 |
# H-Bond Aceptor:   | 0 |
# H-Bond Donor:   | 0 |
# Rings:   | 5 |
# Heavy Atoms:   | 28 |